Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
Complete Title: A Phase 1/2, First-in-Human, Safety and Efficacy Study f NUV-1511 in Adult Patients With Advanced solid Tumors
Trial Phase: I/II
Investigator: Lynn Symonds
NUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors. The Phase 1 portion include patients with advanced solid tumors and is designed to determine the safety and the tolerability of doses of NUV-1511. In Phase 2, NUV-1511 will be given to determine the efficacy of patients with advanced solid tumors.
Keywords:
- Advanced Solid Tumors; Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer, Castration-resistant (CRPC)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.